Adverse Drug Reaction Classification System

ADR Ontology
ADR Term Lipodystrophy acquired
ADR ID BADD_A04820
ADR Hierarchy
14      Metabolism and nutrition disorders
14.08      Lipid metabolism disorders
14.08.04      Lipid metabolism and deposit disorders NEC
14.08.04.008      Lipodystrophy acquired
23      Skin and subcutaneous tissue disorders
23.07      Skin and subcutaneous tissue disorders NEC
23.07.01      Lipodystrophies
23.07.01.003      Lipodystrophy acquired
Description A collection of heterogenous conditions resulting from defective LIPID METABOLISM and characterized by ADIPOSE TISSUE atrophy. Often there is redistribution of body fat resulting in peripheral fat wasting and central adiposity. They include generalized, localized, congenital, and acquired lipodystrophy. [MeSH]
MedDRA Code 10049287
MeSH ID D008060
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Lipodystrophy | Lipodystrophy acquired | Flat buttocks | Peripheral lipodystrophy | Peripheral fat wasting | Lipodystrophies
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D02156Tenofovir disoproxil fumarate--
BADD_D02226Tipranavir--
BADD_D02227Tipranavir disodium--
BADD_D02272Triamcinolone acetonide0.000087%
BADD_D02383Zidovudine0.011051%
The 2th Page    First    Pre   2    Total 2 Pages